Group Information: The ERCHIVES Study Team comprises the authors of this article.
Accepted for Publication: August 2, 2014.
Published Online: December 8, 2014. doi:10.1001/jamainternmed.2014.6502.
Study concept and design: Butt, Yan, Leaf, Klein, Justice.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Butt, Yan, Rimland.
Critical revision of the manuscript for important intellectual content: Butt, Lo Re Rimland, Goetz, Leaf, Freiberg, Klein, Justice, Sherman.
Statistical analysis: Yan, Justice, Sherman.
Obtained funding: Butt.
Administrative, technical, or material support: Butt, Rimland, Leaf.
Study supervision: Butt, Leaf, Sherman.
Conflict of Interest Disclosures: Dr Butt reports receiving grants from Merck during the conduct of the study and grants from Pfizer outside the submitted work. Dr Sherman reports receiving grants from AbbVie, Anadys, Genentech, Gilead, Merck, Novartis, Vertex, and personal fees from Bioline, MedImmune, Merck, Kadmon, Janssen, MedPace, and Synteract, all outside the submitted work. No other disclosures are reported.
Funding/Support: Dr Justice’s time was supported by grants U24 AA020794 and U01 AA020790 from the National Institutes of Health (NIH). This material is the result of work supported with resources and the use of facilities at the VA Pittsburgh Healthcare System and the central data repositories maintained by the VA Information Resource Center, including the National Patient Care Database, Decisions Support System Database and Pharmacy Benefits Management Database.
Role of the Funder/Sponsor: The supporting organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs.
Previous Presentation: This study was presented in part as a poster at the 21st Conference on Retroviruses and Opportunistic Infections; March 3-6, 2014; Boston, Massachusetts.